Navrogen Inc. and Lonza Sign Agreement to Use Lonza's GS Gene Expression System For Navrogen's Anti-HIO Targeting Agents.
In: ENP Newswire, 2019-11-21
Zeitungsartikel
Zugriff:
Titel: |
Navrogen Inc. and Lonza Sign Agreement to Use Lonza's GS Gene Expression System For Navrogen's Anti-HIO Targeting Agents.
|
---|---|
Link: | |
Zeitschrift: | ENP Newswire, 2019-11-21 |
Veröffentlichung: | 2019 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|